Datameds AI Inc MEDS

$1.92 -0.11 (-5.42%)

Valuation

Market cap
6,139,000
Revenue TTM
$23,340,000
Net income TTM
$-101,270,000
P/E (trailing)
0.00
P/E (forward)
—
Profit margin
-433.89%
Debt to equity
-1.01

Trading

Volume
146,400
Avg volume
8,277,396
Day's range
$1.86 – $1.98
Shares out
3,198,000
Stochastic %K
7%
Beta
-3.51
Analysts
—
Price target
$18.74

Price

Company profile

DataMEDS AI, Inc. operates as a health IT company in the United States. The company focuses on the vertical integration of technology, pharmacy, pharmaceutical-adjacent, and telemedicine business units to deliver an enhanced healthcare experience for consumers. It offers tools, such as the EinsteinRx, a pharmacy dispensing AI platform; the PharmacyChain, a smart contracts platform; Patient Rx Adherence Tool; and HubR...

Show more

DataMEDS AI, Inc. operates as a health IT company in the United States. The company focuses on the vertical integration of technology, pharmacy, pharmaceutical-adjacent, and telemedicine business units to deliver an enhanced healthcare experience for consumers. It offers tools, such as the EinsteinRx, a pharmacy dispensing AI platform; the PharmacyChain, a smart contracts platform; Patient Rx Adherence Tool; and HubRx AI. It also operates as a pharmacy distributor; and provides clinical concierge services. DataMEDS AI, Inc., through its subsidiary develops and delivers a portfolio of products to guide physicians and patients with difficult clinical decisions throughout the cancer care continuum. In addition, the company develops and provides functional precision medicine oncology platform. The company was formerly known as Wellgistics Health, Inc. and changed its name to DataMEDS AI, Inc. in July 2026. DataMEDS AI, Inc. was incorporated in 2022 and is based in Tampa, Florida.

Industry
Medical Distribution
Sector
Healthcare
Phone
844 203 6092
Website
https://datamedsai.com
Address
3000 Bayport Drive, Suite 950, Tampa, United States

Latest news

Stocktwits

BioCEOsSukk Nov 1, 8:46 PM
$SCLX $DVLT $SRNE $MEDS I've been following everything for 14 months now and I believe I know what's up. If I'm right, shorts aka stockroaches are DONE. IMO and NFA...
3 replies
ZTRADEZ_LLC Oct 31, 2:17 AM
I want small-caps to be back, those that follow me for that please wait until post mid-terms. Everything should be a decent push then. $MEDS $GDYN $ONEG on watch Monday
1 replies
DELETE26 Oct 30, 4:24 PM
$MEDS I asked an AI if there were any stocks on the verge of a breakout—specifically those with a high volume of short positions and no shares left to borrow (currently 426,000 shares shorted). It indicated that if the price breaks through the 2.2 level, the short sellers will be forced to buy, and that the stock—which previously reached 13 dollars—could potentially hit that level again. I’ve taken a risk with a 150-dollar investment.
0 replies
husnain96 Oct 30, 10:36 AM
$MEDS Meta plans $95B equity raise: Meta (META) plans to raise up to $95B through $35B in stock offerings and a future $60B share sale program to fund AI infrastructure expansion.
0 replies
ZTRADEZ_LLC Oct 29, 7:32 PM
$MEDS Always watching for this one to be beaten down Meds loves the pre-market pops
0 replies
FlipStink Oct 29, 3:07 AM
$DVLT $IBM $MEDS $SCLX $SRNE DataVault files 8k warning it is not a going concern (bankrupt) and has no money for operations, yet this knucklehead gains 2 cents in a 6 cent stock and warns shorts that their end is near. 🤡
0 replies
Ibella0413 Oct 28, 3:26 PM
$MEDS we’re moving people, spread the word!!!!!
0 replies
TheToaster Oct 28, 1:05 PM
$DVLT $IBM $MEDS $SCLX $SRNE LMFAO. SERIOUSLY BRO, WRONG FIGURE OF SPEACH. BEARS STEPPED IN SHIT(AKA REAL MONEY)
0 replies